19,906.4
(-284.09)
(-1.4%)
29 May , 2026 | 04:14 PM
Open
20,241.85
Prev. Close
20,190.5
Market Cap.
₹0
Div Yield
0.5
PE
42.6
PB
42.6
19,817.05
20,357.6
Performance
One Week (%)
-0.71
One Month (%)
5.82
One Year (%)
6.64
YTD (%)
13.49
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,855 | 27,845 | 26,630 | 10,979 |
Cipla Ltd | 1,401 | 1,429.2 | 1,382.7 | 95,40,984 |
Glaxosmithkline Pharmaceuticals Ltd | 2,210.2 | 2,267 | 2,194.4 | 3,04,042 |
J B Chemicals & Pharmaceuticals Ltd | 2,167.4 | 2,239.8 | 2,131 | 3,24,822 |
Pfizer Ltd | 4,598.5 | 4,671.7 | 4,570 | 16,273 |
Jubilant Pharmova Ltd | 995 | 1,002.65 | 978.55 | 1,49,716 |
Apollo Hospitals Enterprise Ltd | 8,176.5 | 8,325 | 8,146 | 10,42,419 |
Dr Reddys Laboratories Ltd | 1,303.5 | 1,328.6 | 1,297.5 | 54,24,483 |
Lupin Ltd | 2,267.7 | 2,301.4 | 2,256.2 | 29,37,904 |
Torrent Pharmaceuticals Ltd | 4,410.8 | 4,575 | 4,356.1 | 30,02,937 |
Ipca Laboratories Ltd | 1,524.4 | 1,618.7 | 1,482.9 | 9,79,166 |
Neuland Laboratories Ltd | 17,088 | 17,170 | 16,675 | 73,932 |
Sun Pharmaceutical Industries Ltd | 1,799.2 | 1,852.8 | 1,785.3 | 1,00,58,572 |
Caplin Point Laboratories Ltd | 2,024.5 | 2,086.5 | 2,012 | 97,307 |
Aurobindo Pharma Ltd | 1,426.4 | 1,453.4 | 1,411 | 24,34,944 |
Natco Pharma Ltd | 1,015.9 | 1,201.9 | 1,000 | 39,36,884 |
Wockhardt Ltd | 2,031.4 | 2,097.4 | 1,872.1 | 1,31,72,612 |
Granules India Ltd | 773.85 | 804.3 | 768.55 | 11,70,367 |
Ajanta Pharma Ltd | 2,928.9 | 3,060.4 | 2,850 | 2,27,318 |
Poly Medicure Ltd | 1,349.7 | 1,397.5 | 1,318 | 4,38,114 |
Gland Pharma Ltd | 2,250 | 2,337.5 | 2,230 | 2,18,609 |
Biocon Ltd | 428.65 | 440 | 425.65 | 62,29,370 |
Emcure Pharmaceuticals Ltd | 1,696 | 1,750 | 1,675 | 2,30,123 |
Alkem Laboratories Ltd | 5,498 | 5,789 | 5,472 | 14,04,988 |
Glenmark Pharmaceuticals Ltd | 2,274.9 | 2,400.7 | 2,257.8 | 13,43,564 |
Zydus Lifesciences Ltd | 1,077.7 | 1,115.5 | 1,071.2 | 45,88,161 |
Divis Laboratories Ltd | 6,667 | 6,849 | 6,590 | 6,12,037 |
Max Healthcare Institute Ltd | 965.1 | 1,002.95 | 955 | 1,53,88,949 |
Fortis Healthcare Ltd | 928.45 | 967.3 | 920 | 30,05,046 |
Syngene International Ltd | 442 | 464.15 | 436.05 | 9,42,298 |
Anthem Biosciences Ltd | 759.95 | 777 | 745.4 | 30,03,554 |
Global Health Ltd | 1,189 | 1,232.9 | 1,170 | 1,61,671 |
Krishna Institute of Medical Sciences Ltd | 758.85 | 787.9 | 751.1 | 3,61,245 |
Rainbow Childrens Medicare Ltd | 1,380.3 | 1,394 | 1,361 | 1,19,276 |
Mankind Pharma Ltd | 2,375.6 | 2,468.8 | 2,363.2 | 23,47,838 |
Dr Lal Pathlabs Ltd | 1,607.4 | 1,638.1 | 1,585.9 | 4,14,912 |
Indegene Ltd | 521.55 | 535 | 508.1 | 5,82,028 |
Narayana Hrudayalaya Ltd | 1,894 | 1,944.5 | 1,868 | 5,37,699 |
Laurus Labs Ltd | 1,362 | 1,393.4 | 1,356.4 | 17,75,559 |
ERIS Lifesciences Ltd | 1,399 | 1,403 | 1,350.8 | 1,74,852 |
Sai Life Sciences Ltd | 1,160 | 1,169.9 | 1,126 | 6,29,048 |
Aster DM Healthcare Ltd | 728.35 | 751.45 | 721.3 | 5,14,480 |
Concord Biotech Ltd | 1,051.2 | 1,123.6 | 1,040.3 | 3,35,959 |
Acutaas Chemicals Ltd | 3,132.5 | 3,184.9 | 2,991 | 6,02,384 |
Cohance Lifesciences Ltd | 431.5 | 435 | 427.2 | 6,09,209 |
Vijaya Diagnostic Centre Ltd | 1,308.5 | 1,322.1 | 1,261.9 | 4,18,625 |
Piramal Pharma Ltd | 172.79 | 175.88 | 171.25 | 26,26,463 |
Blue Jet Healthcare Ltd | 449.35 | 468 | 445 | 13,91,474 |
OneSource Specialty Pharma Ltd | 1,824.6 | 1,888.4 | 1,771.6 | 6,04,575 |
The Indian stock market witnessed a sharp selloff on May 29, 2026, as weak monsoon forecasts, continued FII selling, geopolitical uncertainty surrounding the US-Iran peace deal, and late-session profit booking dragged benchmark indices sharply lower. Sensex fell over 1,092 points, while Nifty declined 1.5%, with IT emerging as the only sectoral gainer amid broad-based weakness across the market.
29 May 2026|05:31 PM
MSCI's latest index rebalancing is expected to drive significant passive fund flows across Indian equities. Federal Bank, MCX, NALCO and Indian Bank emerge as key beneficiaries, while Hyundai Motor India, Jubilant FoodWorks, Kalyan Jewellers and RVNL face selling pressure due to exclusions.
29 May 2026|04:19 PM
Benchmark indices ended range-bound on May 27, 2026, with Nifty and Sensex closing marginally lower amid profit booking, geopolitical concerns, and weakness in financial stocks led by HDFC Bank. Strong gains in metal, media, energy, and auto stocks helped limit market losses despite cautious investor sentiment.
27 May 2026|05:14 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
